Syntro Corp.

Basic Information

10655 Sorrento Valley Rd
San Diego, CA, 92121

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 75


  1. EXPRESSION OF MALARIA CSP ANTIGEN IN RECOMBINANT HERPESVIRUS

    Amount: $500,000.00

    MALARIA IS ONE OF THE MOST IMPORTANT PARASITIC DISEASES OF MAN. IT IS CAUSED BY SPECIES OF THE PROTOZOAN PLASMODIUM WHICH HAVE A COMPLEX LIFE CYCLE OF SEVERAL DEVELOPMENTAL STAGES THAT OCCUR IN BOTH M ...

    SBIR Phase II 1988 Army Department of Defense
  2. VACCINE FOR INFECTIOUS BURSAL DISEASE VIRUS

    Amount: $150,000.00

    THE IMMUNODOMINANT ANTIGEN OF INFECTIOUS BURSAL DISEASE VIRUS HAS BEEN SHOWN TO BE A 32 KD STRUCTURAL PROTEIN. MONOCLONAL ANTIBODY, DIRECTED AGAINST THE PROTEIN, PASSIVELY PROTECTS CHICKS. SYNTRO HAS ...

    SBIR Phase II 1988 Department of Agriculture
  3. ALTERNATIVE SOURCE FOR METAL CHELATION COMPOUNDS

    Amount: $485,655.00

    THERE IS A NEED FOR CHEMICALS WITH A HIGH METAL BINDING CAPACITY WHICH ALSO ALLOWS FOR RECOVERY OF THE METALS IN A CONCENTRATED FORM. THIS CHEMICAL SHOULD PERMIT REPEATED RECYCLING, FUNCTION AT LOW ME ...

    SBIR Phase II 1987 Department of Energy
  4. IMPROVED REAGENTS FOR SYPHILIS DIAGNOSIS

    Amount: $50,000.00

    A PROJECT TO DEVELOP A STATE-OF-THE-ART SERODIAGNOSTIC ASSAY FOR SYPHILIS WITH RECOMBINANT TREPONEMA PALLIDUM ANTIGENS IS PROPOSED. THE DEVELOPMENT OF RECOMBINANT DNA-DERIVED REAGENTS WOULD BE OF GREA ...

    SBIR Phase I 1987 Department of Health and Human Services
  5. VACCINE FOR INFECTIOUS BURSAL DISEASE VIRUS

    Amount: $49,992.00

    N/A

    SBIR Phase I 1987 Department of Agriculture
  6. HUMAN T-CELL LYMPHOTROPIC VIRUS-III (HTLV-III) IS ALMOST CERTAINLY THE CAUSAL AGENT OF THE EPIDEMIC HUMAN DISEASE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS).

    Amount: $50,000.00

    HUMAN T-CELL LYMPHOTROPIC VIRUS-III (HTLV-III) IS ALMOST CERTAINLY THE CAUSAL AGENT OF THE EPIDEMIC HUMAN DISEASE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS). AIDS IS A MAJOR HEALTH PROBLEM IN THE U.S.; ...

    SBIR Phase I 1986 Department of Health and Human Services
  7. EXPRESSION OF MALARIA CSP ANTIGEN IN RECOMBINANT HERPESVIRUS

    Amount: $49,950.00

    N/A

    SBIR Phase I 1986 Army Department of Defense
  8. ALTERNATIVE SOURCE FOR METAL CHELATION COMPOUNDS

    Amount: $49,707.00

    N/A

    SBIR Phase I 1986 Department of Energy
  9. BIOLOGICALLY PRODUCED MACRO-MOLECULES FOR AVIATION MATERIAL

    Amount: $500,000.00

    SYNTRO CORP HAS DEVELOPED THE MEANS OF CONSTRUCTING ARTIFICIAL GENES, AND FOR THE EXPRESSION OF THESE GENES AS MACRO-MOLECULES IN BACTERIA. THE CORPORATION PROPOSES TO PERFECT THIS TECHNOLOGY AND USE ...

    SBIR Phase II 1985 Navy Department of Defense
  10. HUMAN CYTOMEGALOVIRUS (HCMV) IS A SIGNIFICANT HUMAN PATHOGEN.

    Amount: $49,875.00

    HUMAN CYTOMEGALOVIRUS (HCMV) IS A SIGNIFICANT HUMAN PATHOGEN. WHILE HCMV INFECTION DOES NOT PRODUCE DISEASE IN THE MAJORITY OF CASES, MAJOR PROBLEMS MAY DEVELOP FROM CONGENITAL INFECTIONS OR IN IMMUNO ...

    SBIR Phase I 1985 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government